Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
23.02
-0.54 (-2.29%)
At close: Nov 17, 2025, 4:00 PM EST
22.90
-0.12 (-0.52%)
After-hours: Nov 17, 2025, 7:59 PM EST
Avadel Pharmaceuticals Market Cap
Avadel Pharmaceuticals has a market cap or net worth of $2.25 billion as of November 17, 2025. Its market cap has increased by 50.95% in one year.
Market Cap
2.25B
Enterprise Value
2.19B
1-Year Change
50.95%
Ranking
Category
Stock Price
$23.02
Market Cap Chart
Since April 15, 2024, Avadel Pharmaceuticals's market cap has increased from $1.54B to $2.25B, an increase of 46.00%. That is a compound annual growth rate of 26.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 2.25B | 121.97% |
| Dec 31, 2024 | 1.01B | -34.23% |
| Apr 15, 2024 | 1.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |